BioVoice

BioVoice is a standalone media platform dedicated to reporting on the Indian bioscience industry. It features a constantly updated web portal, a digital magazine published twice a year, and an upcoming mobile app. Established in 2015, this dynamic news source bridges the gaps in communication within the bioscience sector, providing more opportunities for engagement and information sharing.

National

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#3352944

India

#268008

Science and Education/Biology

#640

Traffic sources

Monthly visitors

Articles

“Our research specifically focuses on understanding how gene function changes with age”

2 weeks ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Shailendra Vyas CEO and Director, Bioheaven360 Genotec shares details on thecompany’s journey so far, its key offerings, upcoming initiatives, and future plans. What motivated you to take up the challenge of founding a startup? Please share your foundational story with our readers.
“We have invested about $31 million globally including India to enhance research facilities”

3 weeks ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Dr Anil Gulati, Chairman and CEO, Pharmazz Inc. answers our questions on the company’s current operations in India and globally, its R&D initiatives, key disease areas and long-term plans. Pharmazz has been at the forefront of developing innovative therapies for critical conditions. Could you elaborate on your most recent product developments? Pharmazz, Inc.
“The integration of genomics into healthcare will revolutionize personalized care ”

1 month ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Kishore Karumanchi, CEO of aciana shares details on thecompany’s key offerings, upcoming initiatives, technology trends and future plans. What sets aciana apart in the industry and your recent initiatives or technologies that have been pivotal? aciana revolutionizes healthcare with its genetic-based approach and advanced analytics that drive insights across the entire healthcare ecosystem.
Samunnati raises Rs 2,300 crore in FY25, strengthening its position in agri-ecosystem

1 month ago | biovoicenews.com | Rahul Koul

New Delhi: Samunnati, India’s pioneering agri-value chain enabler, has successfully raised INR 2,300 crore in debt funding during FY25, marking a 50% increase over the previous year. It has diversified its sources of lending, leveraging debt market instruments, securitization, and increased bank exposure, which has enabled it to onboard 12 new prominent lenders, bringing the total lender relationships to 46.
FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) - BioVoiceNews

1 month ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Rahul Koul, Chief Editor, BioVoice News spoke to Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) on the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, challenges and much more. Key talk points:♦ Startup Mahakumbh, world’s largest startup event is happening from 3rd to 5th April 2025 in New Delhi.
India’s Push for Eradicating Tuberculosis

2 months ago | biovoicenews.com | Rahul Koul

New Delhi: In 2023, Tuberculosis (TB) reclaimed its position as the leading cause of death from a single infectious agent, surpassing COVID-19, with 1.25 million fatalities worldwide. India, contributing over a quarter of global TB cases, remains a hotspot. Meanwhile, the advancements in treatment, including discovery of the novel drug Bedaquiline, have significantly improved drug-resistant TB management as well as overall survival rates in these patients.
"Vaccines are guardians of our wellbeing"

2 months ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Dr VJA Gutla Harshavardhan, Director General, Indian Vaccine Manufacturers Association (IVMA) shares his insights on the importance of vaccines, evolution of vaccine industry in India and role played by IVMA on the occasion of national immunization day 2025. Dr Harshavardhan, for our readers who may not fully understand the science behind vaccines, could you explain what immunization with vaccines actually is and how it works?
"Vaccines are the guardians of our wellbeing"

2 months ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Dr VJA Gutla Harshavardhan, Director General, Indian Vaccine Manufacturers Association (IVMA) shares his insights on the importance of immunization, vaccine hesitancy and role played by IVMA. Dr Harshavardhan, for our readers who may not fully understand the science behind vaccines, could you explain what immunization with vaccines actually is and how it works? To understand immunization, we must think of it as a training camp for our body’s defence forces.
“Integration of AI & ML to play a critical role in reshaping pharma manufacturing operations”

2 months ago | biovoicenews.com | Rahul Koul

Dr Abdelaziz Toumi, CEO – Lupin Manufacturing Solutions is a passionate leader with a blend of scientific and commercial skills. He brings over 20 years of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America, and Asia. Abdel heads Lupin’s API CDMO business, a division that provides custom development and manufacturing of active pharmaceutical ingredients for clients worldwide.
India’s commendable progress towards being a TB-Free nation - BioVoiceNews

2 months ago | biovoicenews.com | Rahul Koul

Over the years, India has made noteworthy strides in tackling Tuberculosis (TB), signaling a commitment to achieving its ambitious goal of eliminating the disease by 2025, five years ahead of the global Sustainable Development Goal (SDG) target. The rate of TB decline in India from 2015 to 2024 is 17.7% which is double that of the global average of 8.3%. The deaths due to TB have reduced significantly in India by 21.4% in the last 10 years.